Skip to main content

Advertisement

Log in

A promoter that drives gene expression preferentially in male transgenic rats

  • Original Paper
  • Published:
Transgenic Research Aims and scope Submit manuscript

Abstract

Gender-preferential gene expression is a widespread phenomenon in humans. It is important to study how gender differences influence the pathogenesis of various diseases and response to specific drugs. The aim of this study is to determine if the mouse albumin enhancer/promoter may serve as the promoter to introduce gender-preferential gene expression in transgenic animals. We created four independent transgenic rat lines in which the human C-reactive protein transgene was under the control of mouse albumin enhancer/promoter. Quantitative real time RT-PCR analysis showed that transgene expression in the liver of male rats was significantly higher than transgene expression in the female rats (P < 0.05).There was a 5.3-fold (male/female) difference in line-519, and a 12.2-fold (male/female) difference in line-488. Enzyme-linked immunosorbent assay showed that the serum of male transgenic rats had a 13- to 679-fold difference at the protein level on transgene production compared with female transgenic rats. The male-to-female difference in gene expression was 10- to 17-fold in the liver of transgenic rats. Orchiectomy dramatically reduced protein production from the transgene in the liver. Testosterone administration into female rats did not increase the transgene expression, but estrogen administration into the male rats reduced transgene expression. This study provides a valuable tool for investigating the pathological roles of genes that are expressed in a gender-preferential manner in human disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Clark AJ, Bissinger P, Bullock DW, Damak S, Wallace R, Whitelaw CB, Yull F (1994) Chromosomal position effects and the modulation of transgene expression. Reprod Fertil Dev 6(5):589–598

    Article  CAS  PubMed  Google Scholar 

  • Filipiak WE, Saunders TL (2006) Advances in transgenic rat production. Transgenic Res 15(6):673–686

    Article  CAS  PubMed  Google Scholar 

  • Heidecker B, Lamirault G, Kasper EK, Wittstein IS, Champion HC, Breton E, Russell SD, Hall J, Kittleson MM, Baughman KL, Hare JM (2010) The gene expression profile of patients with new-onset heart failure reveals important gender-preferential differences. Eur Heart J 31(10):1188–1196

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kimoto H, Haga S, Sato K, Touhara K (2005) Sex-specific peptides from exocrine glands stimulate mouse vomeronasal sensory neurons. Nature 437(7060):898–901

    Article  CAS  PubMed  Google Scholar 

  • Palmiter RD, Brinster RL (1986) Germ-line transformation of mice. Annu Rev Genet 20:465–499

    Article  CAS  PubMed  Google Scholar 

  • Pfeifer C, Aneja MK, Hasenpusch G, Rudolph C (2011) Adeno-associated virus serotype 9-mediated pulmonary transgene expression: effect of mouse strain, animal gender and lung inflammation. Gene Ther 18(11):1034–1042

    Article  CAS  PubMed  Google Scholar 

  • Si H, Banga RS, Kapitsinou P, Ramaiah M, Lawrence J, Kambhampati G, Gruenwald A, Bottinger E, Glicklich D, Tellis V, Greenstein S, Thomas DB, Pullman J, Fazzari M, Susztak K (2009) Human and murine kidneys show gender- and species-specific gene expression differences in response to injury. PLoS One 4(3):e4802

    Article  PubMed Central  PubMed  Google Scholar 

  • Simunovic F, Yi M, Wang Y, Stephens R, Sonntag KC (2010) Evidence for gender-preferential transcriptional profiles of nigral dopamine neurons in Parkinson disease. PLoS One 5(1):e8856

    Article  PubMed Central  PubMed  Google Scholar 

  • Sugamori KS, Brenneman D, Grant DM (2011) Liver-selective expression of human arylamine N-acetyltransferase NAT2 in transgenic mice. Drug Metab Dispos 39(5):882–890

    Article  CAS  PubMed  Google Scholar 

  • Vawter MP, Evans S, Choudary P, Tomita H, Meador-Woodruff J, Molnar M, Li J, Lopez JF, Myers R, Cox D, Watson SJ, Akil H, Jones EG, Bunney WE (2004) Gender-preferential gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology 29(2):373–384

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zhang W, Bleibel WK, Roe CA, Cox NJ, Eileen Dolan M (2007) Gender-preferential differences in expression in human lymphoblastoid cell lines. Pharmacogenet Genomics 17(6):447–450

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by NIH Grants (HG006173, MD005964, HL095098, RR003034), American Heart Association Grant (09GRNT2300003). We acknowledge Wanda Filipiak for preparation of transgenic rats and the Transgenic Animal Model Core of the University of Michigan’s Biomedical Research Core Facilities.

Conflict of interest

The authors have declared that no competing interests exist.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qing Song.

Additional information

Qiling Li and Yamin Ma have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Q., Ma, Y., Li, W. et al. A promoter that drives gene expression preferentially in male transgenic rats. Transgenic Res 23, 341–349 (2014). https://doi.org/10.1007/s11248-013-9773-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11248-013-9773-9

Keywords

Navigation